Connecticut § 21a-422a Cannabinoid metabolites in bodily fluids: Denial of medical care; actions or proceedings by the Department of Children and Families.

Connecticut Statutes

§ 21a-422a — Cannabinoid metabolites in bodily fluids: Denial of medical care; actions or proceedings by the Department of Children and Families.

Connecticut § 21a-422a

Title 21aConsumer Protection

Ch. 420hRegulation of Adult-Use Cannabis

This text of Connecticut § 21a-422a (Cannabinoid metabolites in bodily fluids: Denial of medical care; actions or proceedings by the Department of Children and Families.) is published on Counsel Stack Legal Research, covering Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Conn. Gen. Stat. § 21a-422a (2026).

Text

The presence of cannabinoid metabolites in the bodily fluids of a person:

(1)With respect to a patient, shall not constitute the use of an illicit substance resulting in denial of medical care, including organ transplantation, and a patient's use of cannabis products may only be considered with respect to evidence-based clinical criteria; and (2) With respect to a parent or legal guardian of a child or newborn infant, or a pregnant woman, shall not form the sole or primary basis for any action or proceeding by the Department of Children and Families, or any successor agencies provided, nothing in this subdivision shall preclude any action or proceeding by such department based on harm or risk of harm to a child or the use of information on the presence of cannabinoid metabolites in the bo

Free access — add to your briefcase to read the full text and ask questions with AI

The presence of cannabinoid metabolites in the bodily fluids of a person: (1) With respect to a patient, shall not constitute the use of an illicit substance resulting in denial of medical care, including organ transplantation, and a patient's use of cannabis products may only be considered with respect to evidence-based clinical criteria; and (2) With respect to a parent or legal guardian of a child or newborn infant, or a pregnant woman, shall not form the sole or primary basis for any action or proceeding by the Department of Children and Families, or any successor agencies provided, nothing in this subdivision shall preclude any action or proceeding by such department based on harm or risk of harm to a child or the use of information on the presence of cannabinoid metabolites in the bodily fluids of any person in any action or proceeding.